• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    9/27/23 12:48:37 PM ET
    $ADES
    $AONC
    $APLS
    $AU
    Major Chemicals
    Industrials
    Medical/Nursing Services
    Health Care
    Get the next $ADES alert in real time by email

    Gainers

    ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 152.8% to $1.09. The company announced the effective date for its reverse stock split after the close. Shareholders voted to approve a reverse split on Aug. 21. After the closing bell on Tuesday, ShiftPixy said the one-for-twenty-four reverse split will take effect on Sept. 30.

    SciSparc Ltd. (NASDAQ:SPRC) gained 120.9% to $0.3450. The company reported its previously announced 1-for-26 reverse share split is expected to be implemented after market close today.

    Rite Aid Corporation (NYSE:RAD) climbed 44% to $0.6175. Consulting firm McKinsey & Company has reached a substantial settlement agreement of $230 million to resolve lawsuits filed by numerous U.S. local governments and school districts, accusing the firm of contributing to the opioid addiction crisis through its consulting work with OxyContin maker Purdue Pharma and other pharmaceutical companies.

    MillerKnoll, Inc. (NASDAQ:MLKN) surged 27% to $24.31 after the company announced better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.

    Biohaven Ltd. (NYSE:BHVN) shares gained 24.6% to $21.99.

    American Strategic Investment Co. (NYSE:NYC) climbed 22.8% to $7.64 after Bellevue Capital Partners, LLC launched a tender offer for shares of the company.

    Inpixon (NASDAQ:INPX) gained 18.4% to $0.1512.

    MSP Recovery, Inc. (NASDAQ:LIFW) shares climbed 18.3% to $0.1799 after falling around 25% on Tuesday.

    Gaucho Group Holdings, Inc. (NASDAQ:VINO) gained 18.2% to $2.4699 after falling over 12% on Tuesday. Gaucho Group recently announced a 1-for-10 reverse stock split.

    Galecto, Inc. (NASDAQ:GLTO) shares climbed 17.3% to $0.6740 after the company announced plans to explore strategic alternatives.

    Phoenix New Media Limited (NYSE:FENG) climbed 16% to $1.3004 as the company announced up to $2 million share repurchase program.

    Ramaco Resources, Inc. (NASDAQ:METC) rose 15.3% to $10.77.

    SoundHound AI, Inc. (NASDAQ:SOUN) gained 15% to $1.84 after DA Davidson initiated coverage on the stock with a Buy rating and $5 price target.

    VBI Vaccines Inc. (NASDAQ:VBIV) rose 14% to $0.7142 as the company Announced interim data from the Phase 1 study of its multivalent pan-coronavirus vaccine candidate, VBI-2901.

    Finance Of America Companies Inc. (NYSE:FOA) gained 14% to $1.39.

    Advanced Emissions Solutions, Inc. (NASDAQ:ADES) climbed 11.7% to $1.7095.

    Warrior Met Coal, Inc. (NYSE:HCC) surged 10.5% to $51.93.

    Immunovant, Inc. (NASDAQ:IMVT) climbed 10.2% to $44.04 as the company reported a proposed offering of $300 million of common stock.

    PROS Holdings, Inc. (NYSE:PRO) surged 9.4% to $35.00. PROS Holdings is working with Qatalyst Partners to explore a sale, Reuters reported.

    WW International, Inc. (NASDAQ:WW) gained 7.2% to $11.03. Craig-Hallum upgraded WW International from Sell to Hold.

    Cardiff Oncology, Inc. (NASDAQ:CRDF) shares gained 7% to $1.73 after the company announced clinical data in pancreatic cancer and small cell lung cancer, including single-agent activity from onvansertib monotherapy.

    Losers

    mCloud Technologies Corp. (NASDAQ:MCLD) shares dipped 45.5% to $0.1569 after the company said it would not meet the listing requirements of the Nasdaq Stock Market LLC.

    Know Labs, Inc. (NYSE:KNW) fell 32.3% to $0.24 after the company announced pricing of a $7 million public offering of common stock.

    Sharps Technology, Inc. (NASDAQ:STSS) fell 31.6% to $0.56 after the company reported a $5.6 million registered direct and private placement priced at the market under Nasdaq rules.

    XWELL, Inc. (NASDAQ:XWEL) dipped 29.9% to $0.1142. XWELL announced a 1-for-20 reverse stock split.

    Minerva Surgical, Inc. (NASDAQ:UTRS) fell 29.6% to $0.1990 after jumping 55% on Tuesday.

    Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) tumbled 26.4% to $1.8099 after the company announced an "at-the-market" equity offering program.

    Femasys Inc. (NASDAQ:FEMY) dipped 25% to $1.11. Femasys shares jumped 346% on Tuesday after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.

    Tharimmune, Inc. (NASDAQ:THAR) fell 24.4% to $0.2222 after surging 33% on Tuesday.

    Conduit Pharmaceuticals Inc. (NASDAQ:CDT) fell 19% to $5.32 after declining more than 36% on Tuesday.

    Cheche Group Inc. (NASDAQ:CCG) declined 17.4% to $13.31.

    NextEra Energy Partners, LP (NYSE:NEP) fell 17.2% to $38.82 after the company announced it is revising its limited partner distribution per unit growth rate to 5% to 8% per year through at least 2026.

    Soleno Therapeutics, Inc. (NASDAQ:SLNO) tumbled 15.8% to $22.55.

    Avinger, Inc. (NASDAQ:AVGR) fell 15.5% to $6.43. Avinger raised gross proceeds of approximately $5.3 million through its at-the-market, selling an aggregate of 596,200 shares at a weighted average price of $8.97.

    DMK Pharmaceuticals Corporation (NASDAQ:DMK) declined 15.2% to $0.6499. The company was recently granted a Canadian patent titled 'An Opioid For Use To Reduce And/Or Treat Drug Addiction.'

    TransCode Therapeutics, Inc. (NASDAQ:RNAZ) fell 13.5% to $0.5969. TransCode Therapeutics recently priced its $8 million public offering of 15.7 million shares at $0.51/share.

    Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) declined 12% to $37.98.

    American Oncology Network, Inc. (NASDAQ:AONC) fell 11.3% to $11.63.

    Axcella Health Inc. (NASDAQ:AXLA) fell 11% to $7.07 after declining around 10% on Tuesday.

    VinFast Auto Ltd. (NASDAQ:VFS) declined 9.3% to $11.68.

    PolyPid Ltd. (NASDAQ:PYPD) fell 9% to $4.8980 after declining 4% on Tuesday. PolyPid recently announced a successful Good Manufacturing Practice (GMP) audit by the Israeli Ministry of Health.

    Traeger, Inc. (NYSE:COOK) fell 8.1% to $2.60. Morgan Stanley downgraded Traeger from Equal-Weight to Underweight and lowered the price target from $4.75 to $3.

    AngloGold Ashanti Limited (NYSE:AU) declined 7.2% to $16.87.

    Wabash National Corporation (NYSE:WNC) fell 7% to $20.60. DA Davidson downgraded Wabash National from Buy to Neutral and announced a $25 price target.

    Now Read This: Ethereum Tops $1,600; Maker, Injective Among Top Gainers

    Get the next $ADES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADES
    $AONC
    $APLS
    $AU

    CompanyDatePrice TargetRatingAnalyst
    Ramaco Resources Inc.
    $METC
    4/21/2026$15.00Sell → Neutral
    Goldman
    Biohaven Ltd.
    $BHVN
    4/13/2026$21.00Buy
    Canaccord Genuity
    Finance of America Companies Inc.
    $FOA
    4/3/2026$22.50Buy
    B. Riley Securities
    Finance of America Companies Inc.
    $FOA
    4/2/2026$22.50Buy
    B. Riley Securities
    Immunovant Inc.
    $IMVT
    3/20/2026$28.00Mkt Perform
    Bernstein
    Apellis Pharmaceuticals Inc.
    $APLS
    3/13/2026$31.00Buy
    Roth Capital
    Traeger Inc.
    $COOK
    3/6/2026$1.50 → $1.00Market Perform
    Telsey Advisory Group
    Galecto Inc.
    $GLTO
    2/17/2026$45.00Buy
    UBS
    More analyst ratings

    $ADES
    $AONC
    $APLS
    $AU
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADES
    $AONC
    $APLS
    $AU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Engel Matthew A bought $174,402 worth of shares (10,600 units at $16.45), increasing direct ownership by 46% to 33,436 units (SEC Form 4)

    4 - Finance of America Companies Inc. (0001828937) (Issuer)

    3/17/26 4:42:00 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    Large owner Cooperman Leon G bought $451 worth of shares (28 units at $16.10) (SEC Form 4)

    4 - Finance of America Companies Inc. (0001828937) (Issuer)

    3/16/26 4:06:53 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    Amendment: Director Childs John W bought $864,115 worth of shares (28,400 units at $30.43) (SEC Form 4)

    4/A - Biohaven Ltd. (0001935979) (Issuer)

    3/9/26 6:12:05 PM ET
    $BHVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADES
    $AONC
    $APLS
    $AU
    SEC Filings

    View All

    SEC Form DEFA14A filed by Cardiff Oncology Inc.

    DEFA14A - Cardiff Oncology, Inc. (0001213037) (Filer)

    4/23/26 4:45:10 PM ET
    $CRDF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEF 14A filed by Cardiff Oncology Inc.

    DEF 14A - Cardiff Oncology, Inc. (0001213037) (Filer)

    4/23/26 4:44:20 PM ET
    $CRDF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEFA14A filed by American Strategic Investment Co.

    DEFA14A - American Strategic Investment Co. (0001595527) (Filer)

    4/23/26 4:40:37 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    $ADES
    $AONC
    $APLS
    $AU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the first quarter 2026 ended March 31, 2026, before market open on Thursday, May 7, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-

    4/23/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Casey's Expands Partnership with SoundHound AI, Leveraging Cutting-Edge AI Agents Across More Than 2600 Stores

    SANTA CLARA, Calif., April 23, 2026 (GLOBE NEWSWIRE) --  SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, today announced the renewal and expansion of its long-standing partnership with Casey's, the third-largest convenience retailer in the United States. The expanded deal highlights the strength of the collaboration, as SoundHound's AI-powered ordering agents have already supported Casey's in handling more than 21 million guest interactions, successfully processing millions of food orders. Casey's has deployed the technology across more than 2,600 locations, helping ensure guests can place orders quickly and easily. Casey's is focused on delivering co

    4/23/26 9:04:00 AM ET
    $CASY
    $SOUN
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    Finance of America Announces First Quarter 2026 Earnings Release and Conference Call on May 5, 2026

    Finance of America Companies Inc. ("Finance of America" or the "Company") (NYSE:FOA), a leading provider of home equity-based financing solutions for a modern retirement, today announced that it will release results for the first quarter ended March 31, 2026 after market closing on Tuesday, May 5, 2026. Webcast and Earnings Conference Call Management will host a webcast and conference call on the same day at 5:00 pm Eastern Time to discuss the Company's results for the first quarter ended March 31, 2026. A copy of the press release and investor presentation will be posted prior to the call under the "Investors" section on Finance of America's investor-oriented website at https://ir.fina

    4/22/26 4:05:00 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    $ADES
    $AONC
    $APLS
    $AU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ramaco Resources upgraded by Goldman with a new price target

    Goldman upgraded Ramaco Resources from Sell to Neutral and set a new price target of $15.00

    4/21/26 7:28:37 AM ET
    $METC
    Coal Mining
    Energy

    Canaccord Genuity initiated coverage on Biohaven with a new price target

    Canaccord Genuity initiated coverage of Biohaven with a rating of Buy and set a new price target of $21.00

    4/13/26 8:51:07 AM ET
    $BHVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    B. Riley Securities initiated coverage on Finance of America with a new price target

    B. Riley Securities initiated coverage of Finance of America with a rating of Buy and set a new price target of $22.50

    4/3/26 10:44:59 AM ET
    $FOA
    Finance: Consumer Services
    Finance

    $ADES
    $AONC
    $APLS
    $AU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Hord Michael Joseph covered exercise/tax liability with 163 shares, decreasing direct ownership by 1% to 14,892 units (SEC Form 4) (for withholding tax)

    4 - Traeger, Inc. (0001857853) (Issuer)

    4/23/26 7:46:01 PM ET
    $COOK
    Consumer Electronics/Appliances
    Consumer Discretionary

    SEC Form 4 filed by Chainey Kimberly

    4 - WARRIOR MET COAL, INC. (0001691303) (Issuer)

    4/22/26 6:37:37 PM ET
    $HCC
    Coal Mining
    Energy

    SEC Form 4 filed by Schnorr Lisa M.

    4 - WARRIOR MET COAL, INC. (0001691303) (Issuer)

    4/22/26 6:27:28 PM ET
    $HCC
    Coal Mining
    Energy

    $ADES
    $AONC
    $APLS
    $AU
    Leadership Updates

    Live Leadership Updates

    View All

    Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company's Board of Directors, effective April 20, 2026. Ms. Thiltgen currently serves as the President of Presbyterian Health Plan and previously served as President & CEO of WellSense Health Plan. As Weight Watchers expands its integrated weight health platform, Ms. Thiltgen brings decades of successful healthcare leadership experience with expertise in: Expanding coverage and access to GLP-1 therapies;Navigating complex regulatory environments, including

    4/20/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth

    Board member and Interim CEO Mani Mohindru, PhD, named President and Chief Executive OfficerAppoints industry veterans Josh Muntner as Chief Financial Officer and Ajay Aggarwal, MD, MBA, as Chief Operating Officer SAN DIEGO, April 09, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced the appointment of Mani Mohindru, PhD, as President and Chief Executive Officer (CEO), following her time as Interim CEO, and that she will continue as a member of the Board. The Company also appointed Josh Muntner as Chief Financial Officer and Ajay Aggarwal, M

    4/9/26 4:01:00 PM ET
    $CRDF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors

    NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed accomplished executives, Lisa Gavales and Sue Gove, as independent members of the Company's Board of Directors, effective April 7, 2026. Ms. Gavales and Ms. Gove will serve as directors until the Company's 2026 annual meeting of shareholders and are expected to stand for election at the annual meeting. Following these appointments, the Board consists of six directors, all of whom are independent. Lisa Gavales and Sue Gove are highly regarded consumer brand leaders with distinct exp

    4/7/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $ADES
    $AONC
    $APLS
    $AU
    Financials

    Live finance-specific insights

    View All

    Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the first quarter 2026 ended March 31, 2026, before market open on Thursday, May 7, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-

    4/23/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Finance of America Announces First Quarter 2026 Earnings Release and Conference Call on May 5, 2026

    Finance of America Companies Inc. ("Finance of America" or the "Company") (NYSE:FOA), a leading provider of home equity-based financing solutions for a modern retirement, today announced that it will release results for the first quarter ended March 31, 2026 after market closing on Tuesday, May 5, 2026. Webcast and Earnings Conference Call Management will host a webcast and conference call on the same day at 5:00 pm Eastern Time to discuss the Company's results for the first quarter ended March 31, 2026. A copy of the press release and investor presentation will be posted prior to the call under the "Investors" section on Finance of America's investor-oriented website at https://ir.fina

    4/22/26 4:05:00 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    SoundHound AI To Report 2026 First Quarter Financial Results, Host Conference Call and Webcast on May 7

    SANTA CLARA, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, today announced that it will report its 2026 first quarter financial results on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast to review the results on the same day. Conference Call and Webcast Information SoundHound AI will host its conference call at 2:00 p.m. PT / 5:00 p.m. ET. A live audio webcast will be available at investors.soundhound.com and a replay will be available at the same location. If you wish to receive company email notifications, please register at https://investors.soundhound.com/i

    4/22/26 4:05:00 PM ET
    $SOUN
    Computer Software: Prepackaged Software
    Technology

    $ADES
    $AONC
    $APLS
    $AU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by PolyPid Ltd.

    SC 13G/A - PolyPid Ltd. (0001611842) (Subject)

    12/12/24 7:05:07 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Finance of America Companies Inc.

    SC 13D/A - Finance of America Companies Inc. (0001828937) (Subject)

    12/11/24 8:30:03 PM ET
    $FOA
    Finance: Consumer Services
    Finance